2016 Hematological Malignancies

Further management

A. Bx B. Salvage chemo + ASCT C. Salvage ISRT ± ASCT D. Salvage chemo + ISRT + ASCT E. Other (e.g. clinical trial)

0%

0% 0% 0% 0%

Bx

Salvage ISRT ± ASCT

Salvage chemo + ASCT

Other (e.g. clinical trial)

Salvage chemo + ISRT ...